Lysosomal destabilization in p53-induced apoptosis.

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• The tumor suppressor wild-type p53 protein is known to induce apoptosis.
• M1-t-p53 myeloid leukemic cells possess a temperature-sensitive p53 protein.
• Shifting cells from 37°C to 32°C induces a conformational change in p53 to its wild-type form.

Purpose of the Study:

• To investigate the mechanism by which p53 induces apoptosis in M1-t-p53 myeloid leukemic cells.
• To determine the role of lysosomes and mitochondria in p53-induced apoptosis.
• To identify potential therapeutic targets for modulating p53-induced cell death.

Main Methods:

• Utilized M1-t-p53 myeloid leukemic cells with temperature-sensitive p53.
• Observed cellular changes upon temperature shift to induce wild-type p53.
• Assessed lysosomal rupture, mitochondrial membrane potential, cytochrome c release, and apoptosis.
• Investigated the inhibitory effects of IL-6 and other compounds (protease inhibitor, Ca(2+)-ATPase inhibitor, antioxidant) on the apoptotic pathway.

Main Results:

• Temperature shift to 32°C induced early lysosomal rupture in M1-t-p53 cells.
• Mitochondrial damage and apoptosis occurred subsequent to lysosomal rupture.
• Interleukin-6 (IL-6) inhibited lysosomal rupture, mitochondrial damage, and apoptosis.
• Specific inhibitors targeting mitochondrial damage did not affect the initial lysosomal destabilization induced by p53.

Conclusions:

• p53 induces apoptosis through a sequential lysosomal-mitochondrial pathway, initiated by lysosomal destabilization.
• This pathway can be pharmacologically dissected using specific inhibitors.
• Understanding p53-induced lysosomal destabilization may lead to novel therapies for diseases involving apoptotic dysregulation.